Chemistry:Istiratumab
From HandWiki
Short description: Monoclonal antibody
Monoclonal antibody | |
---|---|
Type | ? |
Source | Human |
Target | IGF1R, ErbB3 |
Clinical data | |
Other names | MM-141 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C8802H13532N2392O2796S58 |
Molar mass | 199458.51 g·mol−1 |
Istiratumab (MM-141) is an experimental monoclonal antibody for the treatment of cancer. It is a bispecific antibody targeting IGF-1R and ErbB3.[1]
It is in development by Merrimack Pharmaceuticals and was awarded orphan drug status for pancreatic cancer.[2]
References
- ↑ Alternative Names: MM-141. "Istiratumab - AdisInsight". Adisinsight.springer.com. http://adisinsight.springer.com/drugs/800037180.
- ↑ "STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL : USAN (CD-106) ISTIRATUMAB". https://searchusan.ama-assn.org/usan/documentDownload?uri=%2Funstructured%2Fbinary%2Fusan%2Fistiratumab.pdf.
Original source: https://en.wikipedia.org/wiki/Istiratumab.
Read more |